The HIV RNA setpoint theory revisited

BackgroundThe evolution of plasma viral load after HIV infection has been described as reaching a setpoint, only to start rising again shortly before AIDS diagnosis. In contrast, CD4 T-cell count is considered to show a stable decrease. However, characteristics of marker evolution over time depend on the scale that is used to visualize trends. In reconsidering the setpoint theory for HIV RNA, we analyzed the evolution of CD4 T-cell count and HIV-1 RNA level from HIV seroconversion to AIDS diagnosis. Follow-up data were used from two cohort studies among homosexual men (N = 400), restricting to the period before highly active antiretroviral therapy became widely available (1984 until 1996). Individual trajectories of both markers were fitted and averaged, both from seroconversion onwards and in the four years preceding AIDS diagnosis, using a bivariate random effects model. Both markers were evaluated on a scale that is directly related to AIDS risk.ResultsIndividuals with faster AIDS progression had higher HIV RNA level six months after seroconversion. For CD4 T-cell count, this ordering was less clearly present. However, HIV RNA level and CD4 T-cell count showed qualitatively similar evolution over time after seroconversion, also when stratified by rate of progression to AIDS. In the four years preceding AIDS diagnosis, a non-significant change in HIV RNA increase was seen, whereas a significant biphasic pattern was present for CD4 T-cell decline.ConclusionHIV RNA level has more setpoint behaviour than CD4 T-cell count as far as the level shortly after seroconversion is concerned. However, with respect to the, clinically more relevant, marker evolution over time after seroconversion, a setpoint theory holds as much for CD4 T-cell count as for HIV RNA level.

[1]  J M Taylor,et al.  Does the covariance structure matter in longitudinal modelling for the prediction of future CD4 counts? , 1998, Statistics in medicine.

[2]  R. Chaisson,et al.  Human immunodeficiency virus-1 RNA levels and CD4 lymphocyte counts, during treatment for active tuberculosis, in South African patients. , 2003, The Journal of infectious diseases.

[3]  Ciprian M. Crainiceanu,et al.  Bayesian Analysis for Penalized Spline Regression Using WinBUGS , 2005 .

[4]  I Spijkerman,et al.  AIDS prognosis based on HIV‐1 RNA, CD4+ T‐cell count and function: markers with reciprocal predictive value over time after seroconversion , 1997, AIDS.

[5]  Peter Reiss,et al.  Prediction of Residual Time to AIDS and Death Based on Markers and Cofactors , 2003, Journal of acquired immune deficiency syndromes.

[6]  J J Goedert,et al.  Natural history of HIV-1 cell-free viremia. , 1995, JAMA.

[7]  J. Lundgren,et al.  Longitudinal serum HIV RNA quantification: correlation to viral phenotype at seroconversion and clinical outcome , 1996, AIDS.

[8]  R B Geskus,et al.  On the inclusion of prevalent cases in HIV/AIDS natural history studies through a marker-based estimate of time since seroconversion. , 2000, Statistics in medicine.

[9]  D S Stein,et al.  CD4+ lymphocyte cell enumeration for prediction of clinical course of human immunodeficiency virus disease: a review. , 1992, The Journal of infectious diseases.

[10]  Roger Detels,et al.  Plasma Viral Load and CD4+ Lymphocytes as Prognostic Markers of HIV-1 Infection , 1997, Annals of Internal Medicine.

[11]  C. Sabin,et al.  Course of Viral Load Throughout HIV‐1 Infection , 2000, Journal of acquired immune deficiency syndromes.

[12]  B. Berkhout,et al.  Causal Pathways of the Effects of Age and the CCR5-Δ32, CCR2-64I, and SDF-1 3′A Alleles on AIDS Development , 2005, Journal of acquired immune deficiency syndromes.

[13]  J J Goedert,et al.  Longitudinal HIV-1 RNA levels in a cohort of homosexual men. , 1998, Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association.

[14]  D. Thomas,et al.  Simultaneously modelling censored survival data and repeatedly measured covariates: a Gibbs sampling approach. , 1996, Statistics in medicine.

[15]  Sylvia Richardson,et al.  Markov Chain Monte Carlo in Practice , 1997 .

[16]  Stephen P. Brooks,et al.  Review of Markov chain Monte Carlo in practice by WR Gilks, S Richardson & DJ Spiegelhalter , 1997 .

[17]  C. Rouzioux,et al.  Natural history of serum HIV-1 RNA levels in 330 patients with a known date of infection , 2000, AIDS.

[18]  J. Margolick,et al.  Failure of T-cell homeostasis preceding AIDS in HIV-1 infection , 1995, Nature Medicine.

[19]  C. Rouzioux,et al.  Effect of age and exposure group on the onset of AIDS in heterosexual and homosexual HIV‐infected patients , 1994 .

[20]  F. de Wolf,et al.  Biphasic rate of CD4+ cell count decline during progression to AIDS correlates with HIV‐1 phenotype , 1992, AIDS.

[21]  B. Clotet,et al.  Lack of evidence of a stable viral load set‐point in early stage asymptomatic patients with chronic HIV‐1 infection , 1998, AIDS.

[22]  N. Pantazis,et al.  Differences in HIV RNA levels before the initiation of antiretroviral therapy among 1864 individuals with known HIV-1 seroconversion dates , 2004, AIDS.

[23]  D. Ho,et al.  Viral Counts Count in HIV Infection , 1996, Science.

[24]  S. Gore,et al.  Inside methodology: HIV surveillance in prisons. , 1994, AIDS (London).

[25]  J. Margolick,et al.  Changes in T and non-T lymphocyte subsets following seroconversion to HIV-1: stable CD3+ and declining CD3- populations suggest regulatory responses linked to loss of CD4 lymphocytes. The Multicenter AIDS Cohort Study. , 1993, Journal of acquired immune deficiency syndromes.

[26]  J. Hughes,et al.  Mixed Effects Models with Censored Data with Application to HIV RNA Levels , 1999, Biometrics.